Global Genicular Nerve Block and Radiofrequency Ablation Market Growth (Status and Outlook) 2025-2031

The global Genicular Nerve Block and Radiofrequency Ablation market size is predicted to grow from US$ 479 million in 2025 to US$ 1507 million in 2031; it is expected to grow at a CAGR of 21.1% from 2025 to 2031.

Radiofrequency Ablation is a minimally invasive medical procedure used to alleviate chronic knee pain caused by osteoarthritis. It works by using heat generated from radiofrequency energy to target and deactivate specific sensory nerves responsible for transmitting pain signals from the knee to the brain.

United States market for Genicular Nerve Block and Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Genicular Nerve Block and Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Genicular Nerve Block and Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Genicular Nerve Block and Radiofrequency Ablation players cover Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Genicular Nerve Block and Radiofrequency Ablation Industry Forecast” looks at past sales and reviews total world Genicular Nerve Block and Radiofrequency Ablation sales in 2024, providing a comprehensive analysis by region and market sector of projected Genicular Nerve Block and Radiofrequency Ablation sales for 2025 through 2031. With Genicular Nerve Block and Radiofrequency Ablation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genicular Nerve Block and Radiofrequency Ablation industry.

This Insight Report provides a comprehensive analysis of the global Genicular Nerve Block and Radiofrequency Ablation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genicular Nerve Block and Radiofrequency Ablation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genicular Nerve Block and Radiofrequency Ablation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genicular Nerve Block and Radiofrequency Ablation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genicular Nerve Block and Radiofrequency Ablation.

This report presents a comprehensive overview, market shares, and growth opportunities of Genicular Nerve Block and Radiofrequency Ablation market by product type, application, key players and key regions and countries.

Segmentation by Type:
Device
Service

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Stryker
Abbott
Avanos Medical (coolief)
Cosman Medical
Diros Technology
Vantage MedTech
STARmed America
Beijing Neo Science

Please note: The report will take approximately 2 business days to prepare and deliver.